-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
-
Summary
-
Vertex Pharmaceuticals Inc / Ma annual Current Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Vertex Pharmaceuticals Inc / Ma annual Current Income Tax Expense (Benefit) for 2023 was $1.3B, a 9.31% increase from 2022.
- Vertex Pharmaceuticals Inc / Ma annual Current Income Tax Expense (Benefit) for 2022 was $1.19B, a 119% increase from 2021.
- Vertex Pharmaceuticals Inc / Ma annual Current Income Tax Expense (Benefit) for 2021 was $543M, a 324% increase from 2020.
Current Income Tax Expense (Benefit), Annual (USD)
Current Income Tax Expense (Benefit), YoY Annual Growth (%)